(Q41716918)

7 October 2017

1 reference

title

Mechanisms of insulin resistance and new pharmacological approaches to metabolism and diabetic complications (English)

1 reference

7 October 2017

1 reference

Donnelly R

1

1 reference

PubMed ID

9493493

7 October 2017

Qu X

series ordinal

2

1 reference

7 October 2017

1 February 1998

1 reference

Clinical and Experimental Pharmacology and Physiology

7 October 2017

1 reference

7 October 2017

25

1 reference

7 October 2017

2

1 reference

7 October 2017

79-87

1 reference

Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis

7 October 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Why does insulin resistance develop during maturation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Protein kinase C: mediator or inhibitor of insulin action?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Protein kinase C directly phosphorylates the insulin receptor in vitro and reduces its protein-tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Mechanism of hepatic glycogen synthase inactivation induced by Ca2+-mobilizing hormones. Studies using phospholipase C and phorbol myristate acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

A new member of the protein kinase C family, nPKC theta, predominantly expressed in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Expression of the major isoenzyme of protein kinase-C in skeletal muscle, nPKC theta, varies with muscle type and in response to fructose-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Treatment of intact hepatocytes with either the phorbol ester TPA or glucagon elicits the phosphorylation and functional inactivation of the inhibitory guanine nucleotide regulatory protein Gi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Insulin resistance in the conscious spontaneously hypertensive rat: euglycemic hyperinsulinemic clamp study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Increased flux through the hexosamine biosynthesis pathway inhibits glucose transport acutely by activation of protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Molecular characterization of the human beta 3-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

The human beta 3-adrenoceptor: the search for a physiological function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Targeted disruption of the beta 3-adrenergic receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Positional cloning of the mouse obese gene and its human homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Time of Onset of Non-Insulin-Dependent Diabetes Mellitus and Genetic Variation in the β3-Adrenergic–Receptor Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Polymorphism of the glycogen synthase gene in hypertensive and normotensive subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Insulin action and the insulin signaling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

A mutation in the beta 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Association of Trp64Arg mutation of the beta3-adrenergic-receptor with NIDDM and body weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Phenotypic characterization of the Trp64Arg polymorphism in the beta 3-adrenergic receptor gene in normal weight and obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Diabetes complications: why is glucose potentially toxic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Cellular and molecular abnormalities in the vascular endothelium of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

In vitro studies on the action of CS-045, a new antidiabetic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Metabolic effects of troglitazone in the Goto-Kakizaki rat, a non-obese and normolipidemic rodent model of non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

A human peroxisome-proliferator-activated receptor-gamma is activated by inducers of adipogenesis, including thiazolidinedione drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Clinical pharmacology of beta 3-adrenoceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Non-esterified fatty acids regulate lipid and glucose oxidation and glycogen synthesis in healthy man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Suppression of non-esterified fatty acids and triacylglycerol in experimental animals by the adenosine analogue GR79236.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide-dependent protein kinase and protein kinase C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

Effects of phorbol esters on insulin receptor function and insulin action in hepatocytes: evidence for heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1998.TB02181.X

10.1111/J.1440-1681.1998.TB02181.X

21 January 2018

Identifiers

DOI

1 reference

release_tg3n4couvzh5rizth2ys6uh6pm

7 October 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tg3n4couvzh5rizth2ys6uh6pm

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

9493493

1 reference

PubMed ID

9493493